Theodora Karasarides

Theodora Karasarides is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Program Team Leader & Portfolio Leadership for Gene Therapy in Global Development at Ultragenyx Pharmaceutical Inc. since 2021. Prior roles include positions in Early & Late Program Development and Portfolio Strategy at Vertex Pharmaceuticals, and Asset Strategy in the Genetic Therapeutics Franchise at Shire. Additionally, Theodora provided biotechnology consulting at The Delphina Group, led global commercial launches for lysosomal storage disorders at Genzyme, and worked on US product strategy and due diligence at Boston Scientific Corporation. Theodora's career began at Pfizer, focusing on account management and sales within the Cardiovascular Business Unit.